Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy

Periostin is up-regulated in high grade and high stage prostate cancer

(2010) Verena Tischler et al.   BMC CANCER

Advances in proteomic prostate cancer biomarker discovery

(2010) Young Ah Goo et al.   Journal of Proteomics

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The multifaceted role of periostin in tumorigenesis

(2009) Kai Ruan et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Predicting Prostate Cancer Biochemical Recurrence Using a Panel of Serum Proteomic Biomarkers

(2009) C. Nicole Rosenzweig et al.   JOURNAL OF UROLOGY

The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma

(2009) Toshiyuki Tsunoda et al.   PROSTATE

Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer 

(2008) AXEL GLAESSGEN et al.   APMIS

Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer

(2008) Ramesh Ummanni et al.   CANCER LETTERS

Search for Potential Markers for Prostate Cancer Diagnosis, Prognosis and Treatment in Clinical Tissue Specimens Using Amine-Specific Isobaric Tagging (iTRAQ) with Two-Dimensional Liquid Chromatography and Tandem Mass Spectrometry

(2008) Spiros D. Garbis et al.   JOURNAL OF PROTEOME RESEARCH

iTRAQ-Facilitated Proteomic Analysis of Human Prostate Cancer Cells Identifies Proteins Associated with Progression

(2008) Adam Glen et al.   JOURNAL OF PROTEOME RESEARCH

Functional role of periostin in development and wound repair: implications for connective tissue disease

(2008) Douglas W. Hamilton   Journal of Cell Communication and Signaling